ACHV
Achieve Life Sciences, Inc.
$5.21
+8.77%
2026-05-08
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Key Fundamentals
Forward P/E
-4.95
EPS (TTM)
$-1.25
ROE
-257.7%
Profit Margin
0.0%
Debt/Equity
69.50
Price/Book
12.13
Beta
2.25
Market Cap
$503.0M
Avg Volume (10D)
899K
Recent Breakout Signals
No recent breakout signals detected for ACHV.
Recent Price Range (60 Days)
60D High
$5.35
60D Low
$2.62
Avg Volume
1.0M
Latest Close
$5.21
Get breakout alerts for ACHV
Sign up for Breakout Scanner to receive daily notifications when ACHV triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Achieve Life Sciences, Inc. (ACHV) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors ACHV daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ACHV operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.